Clovis Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference

  Clovis Oncology to Present at the 31st Annual J.P. Morgan Healthcare
  Conference

JPMorgan Healthcare Conference 2013

Business Wire

BOULDER, Colo. -- January 2, 2013

Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy,
Chief Executive Officer and President of Clovis will present at the 31^st
Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2012 at 9:00
AM Pacific Time. The conference will be held at the Westin St. Francis Hotel
in San Francisco, CA.

A live webcast of the presentation can be accessed through the investor
relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be available on
the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado, and has additional offices in San
Francisco, California and Cambridge, UK.

Contact:

Clovis Oncology
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com
 
Press spacebar to pause and continue. Press esc to stop.